# OnCo record next-personal (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/next-personal/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "next-personal" ;
  schema:name "NeXT Personal Dx"@en ;
  schema:alternateName "NeXT Personal"@en, "Personalis NeXT Personal"@en, "Tempus xM (NeXT Personal Dx)"@en, "NeXT Personal Dx" ;
  schema:description "Personalis' whole-genome blood test for leftover cancer, which tracks up to 1,800 of the tumour's own mutations and is Medicare-covered in breast and lung cancer."@en ;
  schema:url <https://onco.cc/drugs/next-personal/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.personalis.com/for-clinicians/next-personal-dx/>, <https://www.sec.gov/Archives/edgar/data/1527753/000119312525273416/d158834d8k.htm>, <https://www.sec.gov/Archives/edgar/data/1527753/000119312526211850/psnl-ex99_1.htm>, <https://www.sec.gov/Archives/edgar/data/1527753/000119312526221574/psnl-20260512.htm>, <https://www.sec.gov/Archives/edgar/data/1527753/000119312526232533/psnl-20260519.htm>, <https://www.sec.gov/Archives/edgar/data/1527753/000119312526308488/d68794dex991.htm>, <https://doi.org/10.18632/oncotarget.28565>, <https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58376> ;
  onco:status "established" ;
  onco:tag "test" ;
  onco:modality "Tumour-informed whole-genome ctDNA minimal residual disease test (up to 1,800 variants)" ;
  onco:related <https://onco.cc/drugs/signatera/>, <https://onco.cc/drugs/radar-mrd/>, <https://onco.cc/drugs/precise-mrd/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/wes-wgs/> ;
  onco:companies <https://onco.cc/companies/personalis/>, <https://onco.cc/companies/tempus/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> .